Successful treatment of a 4-year-old girl with pure malignant rhabdoid tumor of the bladder: a case report
Authors:
Open Access
- 1 October 2024
- journal article
- research article
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 13 (10) , 1879-1884
Abstract
Background: Extracranial malignant rhabdoid tumors (eMRTs) are rare, highly aggressive neoplasms, predominantly arising in the kidneys, with bladder involvement being extremely uncommon. Optimal management strategies, particularly bladder-preserving approaches, are not well-established due to the rarity of these cases. Case Description: We report the case of a 4-year-old girl who presented with persistent gross hematuria. Imaging revealed a large bladder mass and histopathological examination confirmed the diagnosis of an extrarenal rhabdoid tumor with loss of SMARCB1 expression. The patient underwent a multimodal treatment approach, including bladder-preserving surgery, 12 cycles of high-dose MRTK-2020 neoadjuvant chemotherapy [comprising actinomycin D, vincristine, doxorubicin, cyclophosphamide (AVDC), ifosfamide, carboplatin, and etoposide (ICE)], followed by adjuvant radiotherapy. Remarkably, the patient achieved complete remission after two cycles of chemotherapy and remained in continuous remission with no evidence of disease at the 15-month follow-up. Conclusions: This case underscores the diagnostic challenges of malignant rhabdoid tumors (MRTs) in bladder pathologies and highlights the significance of considering such tumors in differential diagnoses. Despite the limited evidence base, bladder-preserving surgeries, when feasible, should be considered and accompanied by adjuvant therapies for optimal outcomes. This case illustrates the potential for successful treatment of pure MRTs of the bladder using a combination of surgery, chemotherapy, and radiotherapy.Keywords
This publication has 16 references indexed in Scilit:
- Pure malignant rhabdoid tumour of the bladderCanadian Urological Association Journal, 2014
- Molecularly confirmed primary malignant rhabdoid tumor of the urinary bladder: implications of accurate diagnosisAnnals of Diagnostic Pathology, 2012
- Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: A report of the SIOP renal tumour study groupPediatric Blood & Cancer, 2010
- Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumorsPediatric Blood & Cancer, 2009
- Extra‐renal non‐cerebral rhabdoid tumoursPediatric Blood & Cancer, 2008
- Rhabdoid Tumor of the Kidney in The National Wilms' Tumor Study: Age at Diagnosis As a Prognostic FactorJournal of Clinical Oncology, 2005
- Malignant Extrarenal Rhabdoid Tumor of the Bladder: 9-Year Survival After Chemotherapy and Partial CystectomyJournal of Urology, 2004
- Pure rhabdoid tumor of the bladder.2001
- Malignant rhabdoid tumour of the bladder with immunohistochemical and ultrastructural evidence suggesting histiocytic originHistopathology, 1989
- Ultrastructure of malignant rhabdoid tumor of the kidneyHuman Pathology, 1981